1979 Xmas Bud is a modern hybrid-indica strain with an undocumented lineage. Because the parents are unknown, the genetic history remains a subject of debate. Despite its specific nomenclature, it is categorized as a modern variety rather than an heirloom or landrace strain. Growers can expect a moderate level of difficulty when cultivating this plant in either indoor or outdoor environments, where it typically requires a 60-day flowering period to reach a high yield.

The chemical profile of 1979 Xmas Bud is defined by a terpene composition led by myrcene as the primary constituent, followed by caryophyllene and pinene. This specific arrangement of terpenes characterizes the strain's sensory expression, establishing its aromatic and chemical identity. As a THC-dominant cultivar, its phytochemistry is structured to provide a consistent experience, drawing on the interplay of these three dominant compounds to shape its profile.

In terms of therapeutic and recreational application, the strain consistently produces effects described as relaxed, calm, and focused. Users often turn to 1979 Xmas Bud for the management of pain, stress, and sleep-related concerns. The plant has since established a genetic legacy through its notable offspring, which include Blue Christmas, Christmas in New England, and Xmas Bud 1979.